Aiforia Technologies Oyj (AIFORIA) Stock Overview

Aiforia Technologies Oyj equips pathologists and scientists in preclinical and clinical labs with deep learning artificial intelligence (AI) software for translating images into discoveries, decisions, and diagnoses in Finland and internationally. The company offers Aiforia Create, a platform for the development of AI models that allow experts to automate manual work stages related to the analysis of samples in pathology, standardize analysis, and find hard-to-detect items; Aiforia Clinical Suites, an AI assisted diagnostics for the clinical pathology workflow; Aiforia Hub, a cloud-based platform for teachers to use in histology, anatomy, pathology, and other fields; and Aiforia Custom AI Services. It serves pharmaceutical and biotechnology companies, contract research organizations, clinical laboratories, academic institutions, and other industries. The company was incorporated in 2013 and is headquartered in Helsinki, Finland.